News

Filter

Current filters:

UKPharmaceutical

1 to 9 of 97511 results

US FDA approves NPS Pharma’s Natpara

24-01-2015

The US Food and Drug Administration on Friday approved NPS Pharmaceuticals’ (Nasdaq: NPSP) Natpara…

BiotechnologyNatparaNPS PharmaceuticalsRare diseasesRegulationShireUSA

EMA recommends suspending medicines over flawed studies at GVK Biosciences

EMA recommends suspending medicines over flawed studies at GVK Biosciences

23-01-2015

A number of medicines for which authorization in the European Union was primarily based on clinical studies…

EuropeGVK BiosciencesIndiaPharmaceuticalRegulationResearch

US Senator plans legislation to advance medical research

23-01-2015

In remarks at the Families USA Health Action Conference in Washington DC on January 22, US Senator Elizabeth…

FinancialLegalPharmaceuticalResearchUSA

Array acquires worldwide rights to encorafenib from Novartis

Array acquires worldwide rights to encorafenib from Novartis

23-01-2015

Oncology specialist Array Biopharma has reached an agreement with Swiss drug major Novartis to acquire…

Array BioPharmaencorafenibLicensingNovartisOncologyPharmaceutical

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

Eric Halioua steps down as chief executive of Promethera Biosciences

Eric Halioua steps down as chief executive of Promethera Biosciences

23-01-2015

Belgian pharma company Promethera Biosciences has announced the resignation of its chief executive Eric…

BelgiumBoardroomEric HaliouaPharmaceuticalPromethera Biosciences

FDA's anti-infective committee recommends Astellas' Cresemba

FDA's anti-infective committee recommends Astellas' Cresemba

23-01-2015

The US Food and Drug Administration’s Anti-Infective Drugs Advisory Committee has voted unanimously…

Antibiotics and Infectious diseasesAstellasCresembaPharmaceuticalRegulationUSA

German Federal Joint Committee confirms 'considerable' benefit of Eisai's Halaven in breast cancer

German Federal Joint Committee confirms 'considerable' benefit of Eisai's Halaven in breast cancer

23-01-2015

The German Federal Joint Committee has confirmed the ‘considerable’ additional benefit of Japanese…

EisaiGermanyHalavenOncologyPharmaceuticalRegulation

1 to 9 of 97511 results

Back to top